Suppr超能文献

肝纤维化治疗的研究进展

[Research advances in the treatment of hepatic fibrosis].

作者信息

Xia L, Yang C Q

机构信息

Division of Gastroenterology and Hepatology, Tongji Hospital of Tongji University School of Medicine, Shanghai 200065, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2017 Aug 20;25(8):566-570. doi: 10.3760/cma.j.issn.1007-3418.2017.08.003.

Abstract

Hepatic fibrosis is a common pathological process in the development of various chronic liver diseases into liver cirrhosis. Based on current research findings, it is widely believed that the process of hepatic fibrosis is reversible, and effective treatment cannot only delay the development of hepatic fibrosis into liver cirrhosis, but also alleviate the degree of hepatic fibrosis. Therefore, the research on the treatment of hepatic fibrosis is of great clinical significance. The article reviews the recent research advances in the treatment of hepatic fibrosis.

摘要

肝纤维化是各种慢性肝病发展为肝硬化过程中的常见病理过程。基于目前的研究结果,人们普遍认为肝纤维化过程是可逆的,有效的治疗不仅可以延缓肝纤维化发展为肝硬化,还可以减轻肝纤维化程度。因此,肝纤维化治疗的研究具有重要的临床意义。本文综述了肝纤维化治疗的最新研究进展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验